Investment newsletters’ favorite Dividend Aristocrat stocks
ETFs sold $110.6 million of Medtronic on Friday, with 35 funds buying and 15 selling.
One prioritizes high current payouts with lower costs; the other emphasizes over 25 years of dividend growth. We break down the risk-adjusted returns and sector tilts.
Dividend Aristocrats underperformed SPY in Sept. but rebounded sharply in Oct., narrowing the YTD gap. Check out the Nov. list of best dividend aristocrats here.
SCHD's lower 0.06% expense ratio and stronger 5-year growth ($1,588 vs $1,373) make it compelling for income investors seeking cost efficiency.
The ProShares S&P 500 Dividend Aristocrats ETF trails SPY YTD, but 20 individual Aristocrats are outperforming the ETF. Check out the Aristocrats list here.
Dividend growth stocks have historically weathered market storms.
It's not exciting or flashy, but it has delivered for investors over the past 50 years.
Smart Beta ETF report for NOBL
Smart Beta ETF report for TDV
Here are several different strategies for creating durable passive income streams for your portfolio.
Wall Street’s worst day in weeks hit tech hard. One dividend ETF barely flinched, showing where investors are placing their bets now.
This is the newest page. Registered accounts read further back.